Immunity against measles in populations of women and infants in Poland

Vaccine

Volumn 21, Issue 21-22, 2003, Pages 2948-2953

  Janaszek, Wieslawa ^a   Slusarczyk, Janusz ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

Measles; Passive immunity; Vaccination

Indexed keywords

MEASLES ANTIBODY; MEASLES VACCINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BIRTH; CHILD; CONTROLLED STUDY; EPIDEMIC; FEMALE; GENDER; HUMAN; IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; MOTHER; POLAND; POPULATION RESEARCH; PREGNANCY; PRIORITY JOURNAL; SEX DIFFERENCE; VERTICAL TRANSMISSION;

EID: 0037499420     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00113-0     Document Type: Article

References (30)

1. Aaby P., Anderson M., Knudsen K. Excess mortality after early exposure to measles. Int. J. Epidemiol. 22:1993;156-162.
2. Ramsay M., Gay N., Miller E. The epidemiology of measles in England and Wales: rationale for the 1994 vaccination campaign. Commun. Dis. Rep. Rev. 4:1994;141-146.
3. Miller C., Farrington C.P., Harbert K. The epidemiology of subacute sclerosing panacephalitis in England and Wales 1970-1989. Int. J. Epidemiol. 21:1992;998-1006.
4. Masley N.A., Modlin J.F., Jabbour J.T., Dubey L., Eddins D.L., Ludwig D. Risk factors in subacute sclerosing panencephalitis: a case control study. Am. J. Epidemiol. 11:1980;415-424.
5. Black F.L., Berman L.L., Borgono J.M.et al. Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody. Am. J. Epidemiol. 124:1986;442-452.
6. Krugman S. Further-attenuated measles vaccine: characteristics and use. Rev. Infect. Dis. 5:1983;477-481.
7. Pabst H.F., Spady D.W., Marusyk R.G. Reduced measles immunity in infants in well-vaccinated population. Pediatr. Infect Dis. J. 11:1992;525-529.
8. Carson M.M., Spady D.W., Albrecht P.et al. Measles vaccination of infants in a well-vaccinated population. Pediatr. Infect Dis. J. 14:1995;17-22.
9. Markowitz L.E., Albrecht P., Rhodes P. Changing levels of measles antibody titres in women and children in the United States: impact of response to vaccination. Pediatrics. 97:1996;53-58.
10. de Serres G., Joly J.R., Fauvel M., Meyer F., Mâsse B., Boulianne N. Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles. Vaccine. 5:1997;620-623.
11. Pabst H.F., Spady D.W., Carson M.M., Krezolek M.P., Baretto L., Wittes R.C. Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6-month-old infants. Vaccine. 17:1999;1910-1918.
12. Maldonado Y.A., Lawrance E.C., de Hovitz R., Hartzell A., Albrecht P. Early loss passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics. 96:1995;447-450.
13. Chui L.W., Marusyk R.G., Pabst H.F. Measles virus specific antibody in infants in a highly vaccinated society. J Med. Virol. 33:1991;199-204.
14. de Francisco A, Hall AJ, Unicomb L, et al. Maternal antibody decay in rural Bangladeshi infants: implications to vaccination schedules. Vaccine 1998;16:564-8.
15. Papania M., Baughman A.L., Lee S.et al. Increased susceptibility to measles in infants in United States. Pediatrics. 104:1999;59.
16. Zinkernagek R.M. Immunology taught by viruses. Science. 271:1996;173-178.
17. Siegrist C.A., Barrios C., Martinez X.et al. Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur. J. Immunol. 28:1998;4138-4148.
18. Gans H.A., Arvin A.M., Galinus J., Logan L., de Hovitz R., Maldonado Y. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA. 280:1998;527-532.
19. Gans H., Yasukawa L., Rinki M. Immune responses to measles and mumps vaccination of infants at 6, 9 and 12 months. J. Infect. Dis. 184:2001;817-826.
20. Kumar M.L., Johnson C.E., Chui L.W., Whitwell J.K., Staehle B., Nalin D. Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers. Vaccine. 16:1998;2047-2051.
21. Mitchell L.A., Tingle A.J., Decarie D., Lajeunesse C. Serological responses to measles, mumps, and rubella (MMR) vaccine in healthy infants: failure to respond to measles and mumps components may influence decisions on timing of the second dose of MMR. Can J Public Health. 89:1998;352-358.
22. Van den Hof S., Wallinga J., Widdowson M.A., Conyn-van Spaendock M.A. Protecting the vaccinating population in the face of a measles epidemic: assessing the impact of adjusted vaccination schedules. Epidemiol. Infect. 128:2002;47-57.
23. Van den Hof S., Barbers G.A., de Melker H.E., Conyn-van Spaendonck M.A. Sero-epidemiology of measles antibodies in The Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage. Vaccine. 18:1999;931-940.
24. Janaszek W., Gut W., Gay N.J. The epidemiological of measles in Poland: prevalence of measles virus antibodies in the population. Epidemiol. Infect. 125:2000;385-392.
25. Whittle H.C., Rowland M.G.M., Mann G.F., Lamb W.H., Lewis R.A. Immunisation of 4-6-month-old Gambian infants with Edmonston-Zagreb measles vaccine. Lancet. 2:1984;834-847.
26. Binnendijk R.S., Poelen M.C., Amerongen G., Vries P., Osterhaus A.D.M. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J. Infect. Dis. 175:1997;524-532.
27. Chen R.T., Markowitz L.E., Albrecht P.et al. Measles antibody: reevaluation of protective titres. J. Infect Dis. 162:1990;1036-1042.
28. Samb B., Aaby P., Whittle H.C.et al. Serological status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. PID. 14:1995;203-209.
29. de Serres G, Boulianne N, Meyer F. Measles vaccine efficacy during an outbreak in a highly vaccinated population: incremental increase in protection with age at vaccination. Epidemiol Infect 1995;115:315-23.
30. Recommended childhood immunization schedule: United States, January 1995. Morbid Mortal Wkly Rep 1995 43:959-60.